Human papillomavirus 6 seropositivity is associated with risk of head and neck squamous cell carcinoma, independent of tobacco and alcohol use

Annals of Oncology

Volumn 20, Issue 3, 2009, Pages 534-541

  Furniss, C S ^a   McClean, M D ^b   Smith, J F ^c   Bryan, J ^c   Applebaum, K M ^a   Nelson, H H ^d   Posner, M R ^e   Kelsey, Karl T ^f,g  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON UNIVERSITY   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f BROWN UNIVERSITY   (United States)

^g Center for Environmental Health and Technology   (United States)

Author keywords

Epidemiology; Head and neck squamous cell carcinoma; Human papillomavirus; Risk factors; Serology

Indexed keywords

VIRUS ANTIBODY;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEAD AND NECK CARCINOMA; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PHARYNX CANCER; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SEROLOGY; SEX DIFFERENCE; SMOKING; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ANTIBODIES, VIRAL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; RISK FACTORS; SMOKING;

EID: 61649093570     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn643     Document Type: Article

References (37)

1. American Cancer Society. Cancer Facts and Figures 2006. Atlanta, GA: American Cancer Society 2006.
2. Gillison ML, Koch WM, Capone RB et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92(9): 709-720.
3. Herrero R. Chapter 7: Human papillomavirus and cancer of the upper aerodigestive tract. J Natl Cancer Inst Monogr 2003; 31: 47-51.
4. Furniss CS, McClean MD, Smith JF et al. Human papillomavirus 16 and head and neck squamous cell carcinoma. Int J Cancer 2007; 120(11): 2386-2392.
5. Ringström E, Peters E, Hasegawa M et al. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 2002; 8(10): 3187-3192.
6. D'Souza G, Kreimer AR, Viscidi R et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356(19): 1944-1956.
7. Applebaum KM, Furniss CS, Zeka A et al. Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst 2007; 99(23): 1801-1810. Epub 2007 Nov 27.
8. Schwartz SM, Daling JR, Doody DR et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 1998; 90(21): 1626-1636.
9. Herrero R, Castellsagué X, Pawlita M et al. Human papillomavirus and oral cancer: The International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003; 95(23): 1772-1783.
10. Hobbs CG, Sterne JA, Bailey M et al. Human papillomavirus and head and neck cancer: A systematic review and meta-analysis. Clin Otolaryngol 2006; 31(4): 259-266.
11. Miller CS, Zeuss MS, White DK. Detection of HPV DNA in oral carcinoma using polymerase chain reaction together with in situ hybridization. Oral Surg Oral Med Oral Pathol 1994; 77(5): 480-486.
12. Castellsague X, Munoz N. Chapter 3: Cofactors in human papillomavirus carcinogenesis - role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 2003; (31): 20-28.
13. Shields TS, Brinton LA, Burk RD et al. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus. Cancer Epidemiol Biomarkers Prev 2004; 13(10): 1574-1582.
14. Nair S, Pillai MR. Human papillomavirus and disease mechanisms: relevance to oral and cervical cancers. Oral Dis 2005; 11(6): 350-359.
15. Ritchie JM, Smith EM, Summersgill KF et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 2003; 104(3): 336-344.
16. Stone KM, Karem KL, Sternberg MR et al. Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis 2002; 186(10): 1396-1402.
17. Beskow AH, Josefsson AM, Gyllensten UB. HLA class II alleles associated with infection by HPV16 in cervical cancer in situ. Int J Cancer 2001; 93(6): 817-822.
18. Bohlke K, Harlow BL, Cramer DW et al. Evaluation of a population roster as a source of population controls: The Massachusetts Resident Lists. Am J Epidemiol 1999; 150(4): 354-358.
19. Dias D, Van Doren J, Schlottmann S et al. Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18. Clin Diagn Lab Immunol 2005; 12(8): 959-969.
20. Neeper MP, Hofmann KJ, Jansen KU. Expression of the major capsid protein of human papillomavirus type 11 in Saccharomyces cerevisae. Gene 1996; 180(1-2): 1-6.
21. Rossi JL, Gissmann L, Jansen K, Müller M. Assembly of human papillomavirus type 16 pseudovirions in Saccharomyces cerevisiae. Hum Gene Ther 2000; 11(8): 1165-1176.
22. Hofmann KJ, Cook JC, Joyce JG et al. Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae. Virology 1995; 209(2): 506-518.
23. Hofmann KJ, Neeper MP, Markus HZ et al. Sequence conservation within the major capsid protein of human papillomavirus (HPV) type 18 and formation of HPV-18 virus-like particles in Saccharomyces cerevisiae. J Gen Virol 1996 77(Pt 3)(1): 465-468.
24. Opalka D, Lachman CE, MacMullen SA et al. Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed Luminex assay. Clin Diagn Lab Immunol 2003; 10(1): 108-115.
25. Wideroff L, Schiffman M, Haderer P et al. Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesions. J Infect Dis 1999; 180(5): 1424-1428.
26. Dillner J, Kallings I, Brihmer C et al. Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior. J Infect Dis 1996; 173(6): 1394-1398.
27. Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer - burden and assessment of causality. J Natl Cancer Inst Monogr 2003; (31): 3-13.
28. Wickenden C, Malcolm AD, Byrne M et al. Prevalence of HPV DNA and viral copy numbers in cervical scrapes from women with normal and abnormal cervices. J Pathol 1987; 153(2): 127-135.
29. Slavinsky J 3rd, Kissinger P, Burger L et al. Seroepidemiology of low and high oncogenic risk types of human papillomavirus in a predominantly male cohort of STD clinic patients. Int J STD AIDS 2001; 12(8): 516-523.
30. Castle PE, Shields T, Kirnbauer R et al. Sexual behavior, human papillomavirus type 16 (HPV 16) infection, and HPV 16 seropositivity. Sex Transm Dis 2002; 29(3): 182-187.
31. Poppe WA, Ide PS, Drijkoningen MP et al. Tobacco smoking impairs the local immunosurveillance in the uterine cervix. An immunohistochemical study. Gynecol Obstet Invest 1995; 39(1): 34-38.
32. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev 2003; 16(1): 1-17.
33. Mak KM, Leo MA, Lieber CS. Potentiation by ethanol consumption of tracheal squamous metaplasia caused by vitamin A deficiency in rats. J Natl Cancer Inst 1987; 79(5): 1001-1010.
34. Chellemi SJ, Olson DL, Shapiro S. The association between smoking and aphthous ulcers. A preliminary report. Oral Surg Oral Med Oral Pathol 1970; 29(6): 832-836.
35. Yang CM, Cheng HY, Lin TC et al. Acetone, ethanol and methanol extracts of Phyllanthus urinaria inhibit HSV-2 infection in vitro. Antiviral Res 2005; 67(1): 24-30.
36. Thomas G, Hashibe M, Jacob BJ et al. Risk factors for multiple oral premalignant lesions. Int J Cancer 2003; 107(2): 285-291.
37. Carter JJ, Koutsky LA, Wipf GC et al. The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J Infect Dis 1996; 174(5): 927-936.